Cargando…

FAM115C could be a novel tumor suppressor associated with prolonged survival in pancreatic cancer patients

Hypoxia is a characteristic feature of the tumor microenvironment in pancreatic ductal adenocarcinoma (PDAC). We have recently explored new targeting molecules and pathways in PDAC cells under hypoxic conditions. In this study, we performed a microarray experiment to analyze the genes up-regulated i...

Descripción completa

Detalles Bibliográficos
Autores principales: Saeki, Kiyoshi, Onishi, Hideya, Koga, Satoko, Ichimiya, Shu, Nakayama, Kazunori, Oyama, Yasuhiro, Kawamoto, Makoto, Sakihama, Kukiko, Yamamoto, Takeo, Matsuda, Ryota, Miyasaka, Yoshihiro, Nakamura, Masafumi, Oda, Yoshinao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7052938/
https://www.ncbi.nlm.nih.gov/pubmed/32127956
http://dx.doi.org/10.7150/jca.38399
_version_ 1783502949274615808
author Saeki, Kiyoshi
Onishi, Hideya
Koga, Satoko
Ichimiya, Shu
Nakayama, Kazunori
Oyama, Yasuhiro
Kawamoto, Makoto
Sakihama, Kukiko
Yamamoto, Takeo
Matsuda, Ryota
Miyasaka, Yoshihiro
Nakamura, Masafumi
Oda, Yoshinao
author_facet Saeki, Kiyoshi
Onishi, Hideya
Koga, Satoko
Ichimiya, Shu
Nakayama, Kazunori
Oyama, Yasuhiro
Kawamoto, Makoto
Sakihama, Kukiko
Yamamoto, Takeo
Matsuda, Ryota
Miyasaka, Yoshihiro
Nakamura, Masafumi
Oda, Yoshinao
author_sort Saeki, Kiyoshi
collection PubMed
description Hypoxia is a characteristic feature of the tumor microenvironment in pancreatic ductal adenocarcinoma (PDAC). We have recently explored new targeting molecules and pathways in PDAC cells under hypoxic conditions. In this study, we performed a microarray experiment to analyze the genes up-regulated in PDAC cell lines under hypoxia compared to normoxia, and identified human family with sequence similarity 115, member C (FAM115C) as a candidate gene for further study. Our data showed that FAM115C was overexpressed in PDAC cell lines under hypoxia, and FAM115C inhibition promoted PDAC cell migration and invasion in vitro. FAM115C inhibition did not affect tumor cell proliferation in PDAC. Immunohistochemically, FAM115C expression was observed ubiquitously in normal pancreas, pancreatic intraepithelial neoplasia (PanIN) and PDAC tissue, and it was located mainly in the nucleus but also in the cytoplasm of cells. In qPCR analysis, high expression of FAM115C was correlated with better prognosis in patients with PDAC. Our findings suggest that FAM115C could be a novel tumor suppressor associated with prolonged survival in patients with PDAC.
format Online
Article
Text
id pubmed-7052938
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Ivyspring International Publisher
record_format MEDLINE/PubMed
spelling pubmed-70529382020-03-03 FAM115C could be a novel tumor suppressor associated with prolonged survival in pancreatic cancer patients Saeki, Kiyoshi Onishi, Hideya Koga, Satoko Ichimiya, Shu Nakayama, Kazunori Oyama, Yasuhiro Kawamoto, Makoto Sakihama, Kukiko Yamamoto, Takeo Matsuda, Ryota Miyasaka, Yoshihiro Nakamura, Masafumi Oda, Yoshinao J Cancer Research Paper Hypoxia is a characteristic feature of the tumor microenvironment in pancreatic ductal adenocarcinoma (PDAC). We have recently explored new targeting molecules and pathways in PDAC cells under hypoxic conditions. In this study, we performed a microarray experiment to analyze the genes up-regulated in PDAC cell lines under hypoxia compared to normoxia, and identified human family with sequence similarity 115, member C (FAM115C) as a candidate gene for further study. Our data showed that FAM115C was overexpressed in PDAC cell lines under hypoxia, and FAM115C inhibition promoted PDAC cell migration and invasion in vitro. FAM115C inhibition did not affect tumor cell proliferation in PDAC. Immunohistochemically, FAM115C expression was observed ubiquitously in normal pancreas, pancreatic intraepithelial neoplasia (PanIN) and PDAC tissue, and it was located mainly in the nucleus but also in the cytoplasm of cells. In qPCR analysis, high expression of FAM115C was correlated with better prognosis in patients with PDAC. Our findings suggest that FAM115C could be a novel tumor suppressor associated with prolonged survival in patients with PDAC. Ivyspring International Publisher 2020-02-10 /pmc/articles/PMC7052938/ /pubmed/32127956 http://dx.doi.org/10.7150/jca.38399 Text en © The author(s) This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.
spellingShingle Research Paper
Saeki, Kiyoshi
Onishi, Hideya
Koga, Satoko
Ichimiya, Shu
Nakayama, Kazunori
Oyama, Yasuhiro
Kawamoto, Makoto
Sakihama, Kukiko
Yamamoto, Takeo
Matsuda, Ryota
Miyasaka, Yoshihiro
Nakamura, Masafumi
Oda, Yoshinao
FAM115C could be a novel tumor suppressor associated with prolonged survival in pancreatic cancer patients
title FAM115C could be a novel tumor suppressor associated with prolonged survival in pancreatic cancer patients
title_full FAM115C could be a novel tumor suppressor associated with prolonged survival in pancreatic cancer patients
title_fullStr FAM115C could be a novel tumor suppressor associated with prolonged survival in pancreatic cancer patients
title_full_unstemmed FAM115C could be a novel tumor suppressor associated with prolonged survival in pancreatic cancer patients
title_short FAM115C could be a novel tumor suppressor associated with prolonged survival in pancreatic cancer patients
title_sort fam115c could be a novel tumor suppressor associated with prolonged survival in pancreatic cancer patients
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7052938/
https://www.ncbi.nlm.nih.gov/pubmed/32127956
http://dx.doi.org/10.7150/jca.38399
work_keys_str_mv AT saekikiyoshi fam115ccouldbeanoveltumorsuppressorassociatedwithprolongedsurvivalinpancreaticcancerpatients
AT onishihideya fam115ccouldbeanoveltumorsuppressorassociatedwithprolongedsurvivalinpancreaticcancerpatients
AT kogasatoko fam115ccouldbeanoveltumorsuppressorassociatedwithprolongedsurvivalinpancreaticcancerpatients
AT ichimiyashu fam115ccouldbeanoveltumorsuppressorassociatedwithprolongedsurvivalinpancreaticcancerpatients
AT nakayamakazunori fam115ccouldbeanoveltumorsuppressorassociatedwithprolongedsurvivalinpancreaticcancerpatients
AT oyamayasuhiro fam115ccouldbeanoveltumorsuppressorassociatedwithprolongedsurvivalinpancreaticcancerpatients
AT kawamotomakoto fam115ccouldbeanoveltumorsuppressorassociatedwithprolongedsurvivalinpancreaticcancerpatients
AT sakihamakukiko fam115ccouldbeanoveltumorsuppressorassociatedwithprolongedsurvivalinpancreaticcancerpatients
AT yamamototakeo fam115ccouldbeanoveltumorsuppressorassociatedwithprolongedsurvivalinpancreaticcancerpatients
AT matsudaryota fam115ccouldbeanoveltumorsuppressorassociatedwithprolongedsurvivalinpancreaticcancerpatients
AT miyasakayoshihiro fam115ccouldbeanoveltumorsuppressorassociatedwithprolongedsurvivalinpancreaticcancerpatients
AT nakamuramasafumi fam115ccouldbeanoveltumorsuppressorassociatedwithprolongedsurvivalinpancreaticcancerpatients
AT odayoshinao fam115ccouldbeanoveltumorsuppressorassociatedwithprolongedsurvivalinpancreaticcancerpatients